These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 9131439)
1. Immunomagnetic techniques for the enrichment and detection of isolated breast carcinoma cells in bone marrow and peripheral blood. Naume B; Borgen E; Beiske K; Herstad TK; Ravnås G; Renolen A; Trachsel S; Thrane-Steen K; Funderud S; Kvalheim G J Hematother; 1997 Apr; 6(2):103-14. PubMed ID: 9131439 [TBL] [Abstract][Full Text] [Related]
2. Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation. Naume B; Borgen E; Nesland JM; Beiske K; Gilen E; Renolen A; Ravnås G; Qvist H; Kåresen R; Kvalheim G Int J Cancer; 1998 Nov; 78(5):556-60. PubMed ID: 9808522 [TBL] [Abstract][Full Text] [Related]
3. Detection of isolated tumor cells in peripheral blood and in BM: evaluation of a new enrichment method. Naume B; Borgen E; Tøssvik S; Pavlak N; Oates D; Nesland JM Cytotherapy; 2004; 6(3):244-52. PubMed ID: 15203981 [TBL] [Abstract][Full Text] [Related]
4. Immunomagnetic detection of micrometastatic cells in bone marrow in uveal melanoma patients. Eide N; Faye RS; Høifødt HK; Øvergaard R; Jebsen P; Kvalheim G; Fodstad Ø Acta Ophthalmol; 2009 Nov; 87(8):830-6. PubMed ID: 19055657 [TBL] [Abstract][Full Text] [Related]
5. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. Naume B; Borgen E; Kvalheim G; Kåresen R; Qvist H; Sauer T; Kumar T; Nesland JM Clin Cancer Res; 2001 Dec; 7(12):4122-9. PubMed ID: 11751511 [TBL] [Abstract][Full Text] [Related]
6. Immunomagnetic enrichment of disseminated tumor cells in bone marrow and blood of breast cancer patients by the Thomsen-Friedenreich-Antigen. Schindlbeck C; Stellwagen J; Jeschke U; Karsten U; Rack B; Janni W; Jückstock J; Tulusan A; Sommer H; Friese K Clin Exp Metastasis; 2008; 25(3):233-40. PubMed ID: 18185913 [TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic separation for enrichment and sensitive detection of disseminated tumour cells in patients with head and neck SCC. Partridge M; Phillips E; Francis R; Li SR J Pathol; 1999 Nov; 189(3):368-77. PubMed ID: 10547599 [TBL] [Abstract][Full Text] [Related]
8. Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed. Wiedswang G; Borgen E; Karesen R; Naume B Cytotherapy; 2003; 5(1):40-5. PubMed ID: 12745581 [TBL] [Abstract][Full Text] [Related]
9. Detection of rare human breast cancer cells. Comparison of an immunomagnetic separation method with immunocytochemistry and RT-PCR. Berois N; Varangot M; Osinaga E; Babino A; Caignault L; Musé I; Roseto A Anticancer Res; 1997; 17(4A):2639-46. PubMed ID: 9252694 [TBL] [Abstract][Full Text] [Related]
11. Sensitive detection of micrometastases in bone marrow from patients with breast cancer using immunomagnetic isolation of tumor cells in combination with reverse transcriptase/polymerase chain reaction for cytokeratin-19. Zhong XY; Kaul S; Lin YS; Eichler A; Bastert G J Cancer Res Clin Oncol; 2000 Apr; 126(4):212-8. PubMed ID: 10782894 [TBL] [Abstract][Full Text] [Related]
12. Immunocytochemical detection of isolated epithelial cells in bone marrow: non-specific staining and contribution by plasma cells directly reactive to alkaline phosphatase. Borgen E; Beiske K; Trachsel S; Nesland JM; Kvalheim G; Herstad TK; Schlichting E; Qvist H; Naume B J Pathol; 1998 Aug; 185(4):427-34. PubMed ID: 9828843 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer. Wiedswang G; Borgen E; Schirmer C; Kåresen R; Kvalheim G; Nesland JM; Naume B Int J Cancer; 2006 Apr; 118(8):2013-9. PubMed ID: 16287086 [TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease in bone marrow and peripheral blood of patients with metastatic breast cancer. Bischoff J; Rosenberg R; Dahm M; Janni W; Gutschow K Recent Results Cancer Res; 2003; 162():135-40. PubMed ID: 12790327 [TBL] [Abstract][Full Text] [Related]
15. [Effect of immunomagnetic selection in purging autologous peripheral blood progenitor cell of breast cancer patients]. Han X; Shi Y; Zhang W Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):203-6. PubMed ID: 11953162 [TBL] [Abstract][Full Text] [Related]
16. Immunomagnetic cell enrichment detects more disseminated cancer cells than immunocytochemistry in vitro. Zigeuner RE; Riesenberg R; Pohla H; Hofstetter A; Oberneder R J Urol; 2000 Nov; 164(5):1834-7. PubMed ID: 11025779 [TBL] [Abstract][Full Text] [Related]
17. A European interlaboratory testing of three well-known procedures for immunocytochemical detection of epithelial cells in bone marrow. Results from analysis of normal bone marrow. Borgen E; Pantel K; Schlimok G; Müller P; Otte M; Renolen A; Ehnle S; Coith C; Nesland JM; Naume B Cytometry B Clin Cytom; 2006 Nov; 70(6):400-9. PubMed ID: 16924637 [TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation. Nakamura T; Yasumura T; Hayashi K; Eguchi R; Ide H; Takasaki K; Kasajima T Anticancer Res; 2000; 20(6C):4739-44. PubMed ID: 11205210 [TBL] [Abstract][Full Text] [Related]